Vasoactiveintestinal peptide Vasoactive peptides represent a diverse group of signaling molecules, each playing a crucial role in regulating the delicate balance of our cardiovascular system and beyond. These potent compounds exert significant actions on vascular smooth muscle, influencing blood pressure, blood flow, and organ function. Their study has evolved significantly over time, with foundational research dating back to the mid-20th century, including seminal works by DrVasoactive peptides. State-of-the-art review. S.IVasoactive Peptides. Said in the 1970s and 1980s, highlighting their presence in nerve cells and nerve terminals and their role in mediating both constriction and dilation of blood vessels.
At their core, vasoactive peptides are autacoids—local hormones that act near their site of release. They can either constrict or dilate blood vessels, a fundamental mechanism for controlling systemic hemodynamics. This intricate interplay is vital for maintaining tissue perfusion and responding to physiological demands. The family of these peptides is large and encompasses a wide array of substances, including well-known examples such as Adrenomedullin, Apelin, Bradykinin, Endothelin, GLP-1, IGF-I, Insulin, and natriuretic peptides like ANP and BNP. Each of these peptides possesses unique structures and biological targets.
One of the most extensively studied vasoactive peptides is vasoactive intestinal peptide (VIP). Also known as vasoactive intestinal polypeptide, this peptide hormone is not only vasoactive in the intestine but also functions as a potent vasodilator.Vasoactive Peptides VIP is a neuropeptide that acts as a neuromodulator and neurotransmitter, with established roles in inducing smooth muscle relaxation. Furthermore, VIP stimulates the secretion of water into pancreatic juice and bile, inhibits gastric acid secretion, and influences absorption from the gastrointestinal tractVasoactive Peptides, their Receptors and Drug Development. Its influence extends to neurological functions as well, acting as a mitogenic factor for embryonic neurons in the sympathetic nervous system. Research has even explored its potential therapeutic applications, with recent discussions around informed consent for VIP nasal spray.
The mechanisms by which these peptides exert their effects are multifaceted. They often target the peripheral resistance vessels, capillaries, and veins. Endothelial cells lining these vessels are frequently key players, releasing or responding to vasoactive peptides. The actions of vasoactive peptides are not limited to the vasculature; they can also influence airway and pulmonary vascular smooth muscle, playing a role in relaxation or contraction of airway and pulmonary vascular smooth muscle. This broader impact underscores their systemic importance.作者:LM Greenbaum·1977·被引用次数:8—Largepeptides, specifically the leukokinins and vasoactive intestinal peptide, can alter normal body functions particularly with respect to vascular ...
Disruptions in the vasoactive peptide system have been implicated in various pathological conditions. Abnormal sustained blood pressure levels, for instance, can be significantly influenced by the vasoactive peptide system, often coupled with increased sympathetic nervous system activity. In certain neoplastic diseases, vasoactive peptides may play an important role in fluid movement, contributing to fluid imbalances. Moreover, research has indicated that there is an increase in urine vasoactive peptides and total proteins in certain experimental models, suggesting their involvement in renal or metabolic disturbances.
Drug development has increasingly focused on understanding and manipulating vasoactive peptides and their receptors.Vasoactive Peptides and Substrates and Their Relation to ... Given their critical roles in both physiological processes and disease states, vasoactive peptides with vasoconstrictor properties, in particular, are recognized as playing important roles in many physiological and pathological conditions. The renin-angiotensin system and the kallikrein-kinin system are prime examples of pathways involving peptides that cause vasodilation or vasoconstriction. The clinical significance of these vasoactive agents in regulating vascular tone, reactivity, and structure is well-established, and their dysregulation can contribute to cardiovascular disease.
The ongoing scientific exploration of vasoactive peptides continues to uncover new insights.Vasoactive peptides areautacoids with significant actions on vascular smooth muscleas well as other tissues. They include vasoconstrictors and ... International symposiums, such as the XV International Symposium on Vasoactive Peptides, scheduled to be held at Funda\u00e7\u00e3o Dom Cabral in Nova Lima, MG, on July 20-22, 2025, serve as vital platforms for researchers to share advancements and foster collaboration作者:JC Yugar-Toledo·2018·被引用次数:1—Vasoactive peptidesystems are among the major contributing factors to abnormal sustained blood pressure levels together with increased sympathetic nervous .... This continuous research effort aims to further elucidate the intricate vasoregulatory effects of neuropeptides and their therapeutic potentialRecent advances in vasoactive intestinal peptide physiology and .... Ultimately, a deeper understanding of vasoactive peptides, including vasoactive intestinal peptide, and their complex interactions is fundamental to advancing our understanding of human health and disease.
Join the newsletter to receive news, updates, new products and freebies in your inbox.